Profusa, a digital health company, announced its Board of Directors has launched a process to explore strategic alternatives such as partnerships, business combinations, or asset sales to maximize shareholder value. The company is focusing on near-term goals including advancing CE Mark approval for its Lumee Oxygen platform in Europe and growing revenue from its Healthcare Research business. Profusa has engaged Tungsten Advisors to assist in identifying and executing potential strategic opportunities. The process aims to strengthen the company's scale, execution, and long-term growth prospects, but no specific transaction is guaranteed yet.
Pepeto's latest presale stage sold out ahead of schedule, attracting new wallets at twice last month's rate without paid promotion. Built by the original Pepe token team, Pepeto offers a zero-fee exchange with AI contract checks across major blockcha...
Futu Holdings Limited has repurchased approximately US$418 million worth of its American depositary shares (ADSs) as part of its share buyback program initiated in November 2025. The program allows repurchases up to US$800 million and will continue u...
Skills/Compétences Canada officially launched the 2026 Canadian Skills and Technology Olympiad in Toronto, featuring over 500 competitors across 40+ skilled trades and technology contests. The two-day event at Enercare Centre aims to promote skilled ...
The Skills Canada National Competition 2026 officially began in Toronto, featuring over 500 competitors from across Canada competing in more than 40 skilled trade and technology areas. The event aims to inspire youth to pursue careers in trades and t...
Powerus has been selected to compete in Phase II of the Pentagon's $1 billion Drone Dominance Program with its MatrixFold multi-purpose attack drone. This program aims to procure tens of thousands of low-cost, one-way attack drones to enhance U.S. mi...
